• EV-Transferred ACLY Drives TAM Differentiation in Liver Canc

  2026-06-26

  This study reveals that hepatocellular carcinoma cells exploit extracellular vesicle-transferred ATP-citrate lyase (ACLY) to reprogram monocytes into immunosuppressive tumor-associated macrophages (TAMs), thereby fueling tumor progression. The work identifies a metabolic mechanism for TAM differentiation and suggests that targeting EV-mediated ACLY transfer could enhance immunotherapy efficacy in HCC.

• Lipo3K Transfection Reagent: High-Efficiency Delivery for Ch

  2026-06-26

  Lipo3K Transfection Reagent delivers robust nucleic acid delivery—even in difficult-to-transfect cell types—while minimizing cytotoxicity and streamlining downstream analyses. Its unique enhancer and compatibility with serum make it a versatile tool for cutting-edge functional genomics, resistance modeling, and RNA interference studies.

• Cy3 Goat Anti-Mouse IgG (H+L) Antibody: Technical Use Guide

  2026-06-25

  The Cy3 Goat Anti-Mouse IgG (H+L) Antibody enables sensitive, specific detection of mouse immunoglobulins in fluorescence-based immunoassays. It is intended for research workflows such as immunofluorescence, flow cytometry, and western blotting, and should not be used for diagnostic or non-mouse systems.

• NP-40 Lysis Buffer: Optimizing Non-Denaturing Protein Extrac

  2026-06-25

  NP-40 Lysis Buffer enables gentle, high-yield extraction of native protein complexes from animal, plant, fungal, and bacterial cells, preserving functional interactions for advanced assays. Its robust inhibitor cocktail and non-denaturing formulation make it the buffer of choice for reproducible results in neuroimmunology, co-IP, and phosphoprotein workflows.

• BX795: A Potent PDK1 Inhibitor for Cancer and Immune Pathway

  2026-06-24

  BX795 is a highly selective small molecule ATP-competitive PDK1 inhibitor with nanomolar potency. It also inhibits TBK1 and IKKε, bridging PI3K/Akt/mTOR signaling and innate immune modulation. BX795's efficacy and selectivity are well-documented in both kinase and cell-based assays.

• HyperScript RT SuperMix for qPCR: Advancing cDNA Synthesis P

  2026-06-23

  HyperScript™ RT SuperMix for qPCR enables accurate, reproducible cDNA synthesis from even the most challenging RNA samples, excelling in low input and complex secondary structure contexts. Its robust performance streamlines gene expression analysis workflows, as demonstrated in cutting-edge neurodegenerative disease research.

• gamma-Glu-Cys (γ-Glu-Cys): Technical Protocols and QC Guidan

  2026-06-23

  gamma-Glu-Cys (γ-Glu-Cys) is a high-purity substrate essential for glutathione biosynthesis and thiol-reactive peptide workflows, particularly in glutathione metabolism research and plant stress adaptation studies. This product should be used strictly in controlled laboratory settings and is not appropriate for diagnostic or medical purposes. Researchers benefit from its defined solubility and stability profile, but must avoid long-term storage of solutions to maintain experimental reproducibility.

• Rotigotine Hydrochloride: Neuroprotection and LUTS Modulatio

  2026-06-22

  Explore Rotigotine hydrochloride as a dopamine D2/D3 receptor agonist with unique neuroprotective and lower urinary tract effects in Parkinson's disease research. This article delivers advanced scientific insight, protocol guidance, and translational impact beyond existing content.

• L-Glutathione Reduced: Strategic Redox Control in Translatio

  2026-06-22

  This thought-leadership article explores how mechanistic understanding of L-Glutathione Reduced empowers translational researchers to dissect redox vulnerabilities, streamline GST affinity workflows, and address emerging challenges in cancer and cardiovascular disease. Bridging cutting-edge findings in metabolic reprogramming and oxidative stress with actionable protocol guidance, the piece establishes new standards for experimental rigor and translational impact, while contextualizing APExBIO’s product advantage.

• Bufalin-CRISPR Nanomedicine Induces Pyroptosis and Enhances

  2026-06-21

  Liu et al. (2025) report a calcium lactate nanoparticle co-delivery system for bufalin and CRISPR/Cas9 targeting CD47, enabling synergistic induction of pyroptosis, apoptosis, and M1 macrophage polarization in colorectal cancer. This strategy demonstrates potent local and systemic antitumor immunity, suggesting a promising avenue to overcome immunotherapy resistance.

• APOL1 Evolution, Isoforms, and APOL3 Interactions in Renal I

  2026-06-20

  This article reviews a pivotal study elucidating how the molecular evolution of APOL1, its splice isoforms, and protein interactions with APOL3 contribute to both innate immunity and increased risk of kidney injury. Integration of population genetics with cellular analysis offers a cohesive framework for understanding APOL1-driven cytotoxicity, informing future research into disease mechanisms.

• IEM 1460: Optimizing AMPA Receptor Blockade in Neuroscience

  2026-06-19

  This article addresses common laboratory challenges in excitotoxicity and neuroprotection research, illustrating how IEM 1460 (SKU B6811) serves as a reproducible, high-purity AMPA receptor blocker. Through scenario-driven Q&A, it offers evidence-backed guidance on protocol optimization, assay design, and product reliability, with actionable references for bench scientists.

• Pterostilbene Enhances Mitophagy to Delay Dermal Fibroblast

  2026-06-19

  Zhou et al. (2025) demonstrate that pterostilbene delays senescence in human dermal fibroblasts by improving mitochondrial quality through enhanced mitophagy. This work highlights mitochondrial quality control as a promising target to counteract both intrinsic and extrinsic skin aging.

• Peroxidasin Drives Glioblastoma Progression via LDHA-Mediate

  2026-06-18

  This study identifies peroxidasin (PXDN) as a critical regulator of glycolytic metabolism in glioblastoma, demonstrating its role in tumor progression through modulation of LDHA expression. The findings provide a mechanistic rationale for targeting PXDN-driven metabolic reprogramming in GBM and offer a biomarker for diagnostic and therapeutic development.

• Trypsin in Translational Research: Mechanistic Leverage for

  2026-06-18

  This thought-leadership article explores the evolving role of Trypsin (BA5744) as a serine protease in translational research. Focusing on its mechanistic action in lysine and arginine hydrolysis, the article bridges new insights from R-loop homeostasis and DNA damage research with practical guidance for cell culture, wound healing, and membrane fusion applications. The discussion integrates evidence from recent literature on FTSJ3, R-loops, and chemosensitivity, offering strategic recommendations for researchers aiming to translate basic science findings into actionable workflows. APExBIO's Trypsin (BA5744) is highlighted as an advanced reagent supporting emerging experimental paradigms.

485 records 9/33 page Previous Next First page 上5页 678910 下5页 Last page